Stephen Winchester
Overview
Explore the profile of Stephen Winchester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winchester S, Castellarnau A, Jabbar K, Nadir M, Ranasinghe K, Masramon X, et al.
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339209
Background/objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe illness for vulnerable groups. Methods: This was...
2.
Palmer B, Tang A, Winchester S, Atkins M, Barton S, Kelleher P
Int J STD AIDS
. 2023 Dec;
35(4):314-318.
PMID: 38093464
Background: Herpes simplex virus (HSV) is a common infection, affecting the majority of the population by age of 50. Recurrent symptomatic outbreaks, experienced by a minority, have significant psychological and...
3.
Tandon M, Wu W, Moore K, Winchester S, Tu Y, Miller C, et al.
Lancet Reg Health Southeast Asia
. 2022 Nov;
7:100110.
PMID: 36373109
[This corrects the article DOI: 10.1016/j.lansea.2022.100036.].
4.
Tandon M, Wu W, Moore K, Winchester S, Tu Y, Miller C, et al.
Lancet Reg Health Southeast Asia
. 2022 Jul;
3:100036.
PMID: 35784831
Background: Additional outpatient therapies which are readily accessible will be essential to reduce COVID-19 illness progression in high risk individuals. Especially as the virus continues to mutate with greater transmissibility...
5.
Winchester S, John S, Jabbar K, John I
J Infect
. 2021 May;
83(2):237-279.
PMID: 33992687
Baek et al. investigated the duration of COVID-19 virus shedding in infected patients and demonstrated that even in patients demonstrating prolonged viral clearance, the virus was no longer viable after...
6.
Carreras-Abad C, Cochet M, Hall T, Ramkhelawon L, Khalil A, Peregrine E, et al.
Health Technol Assess
. 2019 Dec;
23(67):1-40.
PMID: 31855555
Background: Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic...